To The Moon
Home
News
TigerAI
Log In
Sign Up
ANGELINE
+Follow
Posts · 0
Posts · 0
Following · 0
Following · 0
Followers · 0
Followers · 0
ANGELINE
ANGELINE
·
02-15
CRo s sees next in 2026
看
221
回复
Comment
点赞
2
编组 21备份 2
Share
Report
ANGELINE
ANGELINE
·
2025-11-27
$Tiger Brokers(TIGR)$
看
651
回复
Comment
点赞
1
编组 21备份 2
Share
Report
ANGELINE
ANGELINE
·
2025-02-25
$Apple(AAPL)$
看
2.25K
回复
Comment
点赞
1
编组 21备份 2
Share
Report
ANGELINE
ANGELINE
·
2024-07-23
$NVIDIA Corp(NVDA)$
看
2.42K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
ANGELINE
ANGELINE
·
2022-01-15
[Cool]
看
3.21K
回复
Comment
点赞
1
编组 21备份 2
Share
Report
ANGELINE
ANGELINE
·
2022-01-07
D//
@ANGELINE
:T
Apple iPhone 13
@ANGELINE：
Apple iPhone 13 mini cost $699 and iPhone 13 cost $1399 (price as last year)
Apple iPhone 13
看
3.46K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
ANGELINE
ANGELINE
·
2021-09-15
Apple iPhone 13
Apple iPhone 13 mini cost $699 and iPhone 13 cost $1399 (price as last year)
看
4.50K
回复
22
点赞
3
编组 21备份 2
Share
Report
Apple iPhone 13
ANGELINE
ANGELINE
·
2021-08-13
[Miser]
Sony delays release of ‘Venom’ sequel amid delta surge
3-week delay suggests studio believes current surge will be brief. NEW YORK — In the biggest sign ye
Sony delays release of ‘Venom’ sequel amid delta surge
看
4.31K
回复
7
点赞
Like
编组 21备份 2
Share
Report
ANGELINE
ANGELINE
·
2021-08-10
[Miser]
3D Systems Corp surged more than 20% in early trading
3D Systems Corp surged more than 20% in early trading after the company announced better-than-expect
3D Systems Corp surged more than 20% in early trading
看
3.10K
回复
2
点赞
1
编组 21备份 2
Share
Report
ANGELINE
ANGELINE
·
2021-08-09
Great
Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd
JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of Pfizer's COVID-19 vaccine felt
Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd
看
3.90K
回复
1
点赞
1
编组 21备份 2
Share
Report
Load more
Most Discussed
{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3584363966051201","uuid":"3584363966051201","gmtCreate":1621270406461,"gmtModify":1621303108805,"name":"ANGELINE","pinyin":"angeline","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/07743f37ca0238b3fc5f71f589bbfd48","hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","hatId":"award-c0e90532fb42ac6de18e25e95db73047","hatName":"2023新年头像框","vip":1,"status":2,"fanSize":7,"headSize":70,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":5,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":532776700187376,"gmtCreate":1771093997954,"gmtModify":1771094002209,"author":{"id":"3584363966051201","authorId":"3584363966051201","name":"ANGELINE","avatar":"https://static.tigerbbs.com/07743f37ca0238b3fc5f71f589bbfd48","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584363966051201","idStr":"3584363966051201"},"themes":[],"title":"","htmlText":"CRo s sees next in 2026 ","listText":"CRo s sees next in 2026 ","text":"CRo s sees next in 2026","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/532776700187376","isVote":1,"tweetType":1,"viewCount":221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":504752567198248,"gmtCreate":1764238847045,"gmtModify":1764238850151,"author":{"id":"3584363966051201","authorId":"3584363966051201","name":"ANGELINE","avatar":"https://static.tigerbbs.com/07743f37ca0238b3fc5f71f589bbfd48","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584363966051201","idStr":"3584363966051201"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a> ","listText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a> ","text":"$Tiger Brokers(TIGR)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/504752567198248","isVote":1,"tweetType":1,"viewCount":651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":407394792145128,"gmtCreate":1740494601352,"gmtModify":1740494606483,"author":{"id":"3584363966051201","authorId":"3584363966051201","name":"ANGELINE","avatar":"https://static.tigerbbs.com/07743f37ca0238b3fc5f71f589bbfd48","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584363966051201","idStr":"3584363966051201"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$ </a> ","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$ </a> ","text":"$Apple(AAPL)$","images":[{"img":"https://community-static.tradeup.com/news/353a82ada3209750814b7eed840da230","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/407394792145128","isVote":1,"tweetType":1,"viewCount":2254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":330709954617400,"gmtCreate":1721745644177,"gmtModify":1721878689043,"author":{"id":"3584363966051201","authorId":"3584363966051201","name":"ANGELINE","avatar":"https://static.tigerbbs.com/07743f37ca0238b3fc5f71f589bbfd48","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584363966051201","idStr":"3584363966051201"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$ </a> ","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$ </a> ","text":"$NVIDIA Corp(NVDA)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/330709954617400","isVote":1,"tweetType":1,"viewCount":2421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9005872546,"gmtCreate":1642260183375,"gmtModify":1676533696210,"author":{"id":"3584363966051201","authorId":"3584363966051201","name":"ANGELINE","avatar":"https://static.tigerbbs.com/07743f37ca0238b3fc5f71f589bbfd48","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584363966051201","idStr":"3584363966051201"},"themes":[],"htmlText":"[Cool] ","listText":"[Cool] ","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":5,"link":"https://ttm.financial/post/9005872546","isVote":1,"tweetType":1,"viewCount":3208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006900145,"gmtCreate":1641567458170,"gmtModify":1676533630019,"author":{"id":"3584363966051201","authorId":"3584363966051201","name":"ANGELINE","avatar":"https://static.tigerbbs.com/07743f37ca0238b3fc5f71f589bbfd48","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584363966051201","idStr":"3584363966051201"},"themes":[],"htmlText":"D//<a href=\"https://ttm.financial/U/3584363966051201\">@ANGELINE</a>:T","listText":"D//<a href=\"https://ttm.financial/U/3584363966051201\">@ANGELINE</a>:T","text":"D//@ANGELINE:T","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006900145","repostId":"882963178","repostType":1,"repost":{"id":882963178,"gmtCreate":1631647589094,"gmtModify":1676530598517,"author":{"id":"3584363966051201","authorId":"3584363966051201","name":"ANGELINE","avatar":"https://static.tigerbbs.com/07743f37ca0238b3fc5f71f589bbfd48","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584363966051201","idStr":"3584363966051201"},"themes":[],"title":"Apple iPhone 13","htmlText":"Apple iPhone 13 mini cost $699 and iPhone 13 cost $1399 (price as last year)","listText":"Apple iPhone 13 mini cost $699 and iPhone 13 cost $1399 (price as last year)","text":"Apple iPhone 13 mini cost $699 and iPhone 13 cost $1399 (price as last year)","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/882963178","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":3456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882963178,"gmtCreate":1631647589094,"gmtModify":1676530598517,"author":{"id":"3584363966051201","authorId":"3584363966051201","name":"ANGELINE","avatar":"https://static.tigerbbs.com/07743f37ca0238b3fc5f71f589bbfd48","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584363966051201","idStr":"3584363966051201"},"themes":[],"title":"Apple iPhone 13","htmlText":"Apple iPhone 13 mini cost $699 and iPhone 13 cost $1399 (price as last year)","listText":"Apple iPhone 13 mini cost $699 and iPhone 13 cost $1399 (price as last year)","text":"Apple iPhone 13 mini cost $699 and iPhone 13 cost $1399 (price as last year)","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":3,"commentSize":22,"repostSize":3,"link":"https://ttm.financial/post/882963178","isVote":1,"tweetType":1,"viewCount":4503,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894269351,"gmtCreate":1628830005273,"gmtModify":1676529868429,"author":{"id":"3584363966051201","authorId":"3584363966051201","name":"ANGELINE","avatar":"https://static.tigerbbs.com/07743f37ca0238b3fc5f71f589bbfd48","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584363966051201","idStr":"3584363966051201"},"themes":[],"htmlText":"[Miser] ","listText":"[Miser] ","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/894269351","repostId":"1106453071","repostType":4,"repost":{"id":"1106453071","kind":"news","pubTimestamp":1628819127,"share":"https://ttm.financial/m/news/1106453071?lang=en_US&edition=fundamental","pubTime":"2021-08-13 09:45","market":"us","language":"en","title":"Sony delays release of ‘Venom’ sequel amid delta surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1106453071","media":"Market Watch","summary":"3-week delay suggests studio believes current surge will be brief.\nNEW YORK — In the biggest sign ye","content":"<p><i>3-week delay suggests studio believes current surge will be brief.</i></p>\n<p>NEW YORK — In the biggest sign yet that Hollywood’s fall plans are being altered by the coronavirus surge driven by the delta variant, Sony Pictures on Thursday delayed the release of the big-budget sequel “Venom: Let There Be Carnage.”</p>\n<p>Instead of opening in theaters Sept. 24, the “Venom” sequel will now debut Oct. 15. The film, starring Tom Hardy, had already been delayed numerous times during earlier stages of the pandemic.</p>\n<p>But after constant turmoil, the fall movie calendar has stayed relatively calm until recently. Last week, <a href=\"https://laohu8.com/S/VIAC\">Viacom CBS</a> Paramount Pictures postponed the release of “Clifford the Big Red Dog,” citing the delta variant.</p>\n<p>What “Venom” and “Clifford” have in common is that they’re planned as theater-only releases. <a href=\"https://laohu8.com/S/SONY\">Sony</a> doesn’t have a major streaming platform the way <a href=\"https://laohu8.com/S/DIS\">Walt Disney</a> and <a href=\"https://laohu8.com/S/T\">AT&T Inc</a>'s Warner Bros. do. Those studios have been relaying partly on subscription boosts or digital rentals to offset lost box office. The original “Venom” earned $856 million globally in 2018.</p>\n<p>After ramping-up ticket sales, the box office has turned south in recent weeks. After Disney’s “Jungle Cruise” underperformed in late July, Warner Bros.’ “The Suicide Squad” opened with an underwhelming $26.2 million last weekend. Analysts have said the delta variant is keeping many moviegoers home.</p>\n<p>But the “Venom” delay — relatively short compared to the postponements of last year — also suggests the film industry is banking on the current surge fading quickly. This weekend, Disney will release the 20th Century Fox production “Free Guy,” with Ryan Reynolds, only in theaters.</p>","source":"lsy1616996754749","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sony delays release of ‘Venom’ sequel amid delta surge</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSony delays release of ‘Venom’ sequel amid delta surge\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 09:45 GMT+8 <a href=https://www.marketwatch.com/story/sony-delays-release-of-venom-sequel-amid-delta-surge-01628800740?mod=home-page><strong>Market Watch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>3-week delay suggests studio believes current surge will be brief.\nNEW YORK — In the biggest sign yet that Hollywood’s fall plans are being altered by the coronavirus surge driven by the delta variant...</p>\n\n<a href=\"https://www.marketwatch.com/story/sony-delays-release-of-venom-sequel-amid-delta-surge-01628800740?mod=home-page\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SONY":"索尼"},"source_url":"https://www.marketwatch.com/story/sony-delays-release-of-venom-sequel-amid-delta-surge-01628800740?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106453071","content_text":"3-week delay suggests studio believes current surge will be brief.\nNEW YORK — In the biggest sign yet that Hollywood’s fall plans are being altered by the coronavirus surge driven by the delta variant, Sony Pictures on Thursday delayed the release of the big-budget sequel “Venom: Let There Be Carnage.”\nInstead of opening in theaters Sept. 24, the “Venom” sequel will now debut Oct. 15. The film, starring Tom Hardy, had already been delayed numerous times during earlier stages of the pandemic.\nBut after constant turmoil, the fall movie calendar has stayed relatively calm until recently. Last week, Viacom CBS Paramount Pictures postponed the release of “Clifford the Big Red Dog,” citing the delta variant.\nWhat “Venom” and “Clifford” have in common is that they’re planned as theater-only releases. Sony doesn’t have a major streaming platform the way Walt Disney and AT&T Inc's Warner Bros. do. Those studios have been relaying partly on subscription boosts or digital rentals to offset lost box office. The original “Venom” earned $856 million globally in 2018.\nAfter ramping-up ticket sales, the box office has turned south in recent weeks. After Disney’s “Jungle Cruise” underperformed in late July, Warner Bros.’ “The Suicide Squad” opened with an underwhelming $26.2 million last weekend. Analysts have said the delta variant is keeping many moviegoers home.\nBut the “Venom” delay — relatively short compared to the postponements of last year — also suggests the film industry is banking on the current surge fading quickly. This weekend, Disney will release the 20th Century Fox production “Free Guy,” with Ryan Reynolds, only in theaters.","news_type":1,"symbols_score_info":{"SONY":0.9}},"isVote":1,"tweetType":1,"viewCount":4308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":896778915,"gmtCreate":1628607766537,"gmtModify":1676529796591,"author":{"id":"3584363966051201","authorId":"3584363966051201","name":"ANGELINE","avatar":"https://static.tigerbbs.com/07743f37ca0238b3fc5f71f589bbfd48","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584363966051201","idStr":"3584363966051201"},"themes":[],"htmlText":"[Miser] ","listText":"[Miser] ","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/896778915","repostId":"1111125748","repostType":4,"repost":{"id":"1111125748","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628602690,"share":"https://ttm.financial/m/news/1111125748?lang=en_US&edition=fundamental","pubTime":"2021-08-10 21:38","market":"us","language":"en","title":"3D Systems Corp surged more than 20% in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1111125748","media":"Tiger Newspress","summary":"3D Systems Corp surged more than 20% in early trading after the company announced better-than-expect","content":"<p><b>3D</b> <b>Systems</b> <b>Corp</b> surged more than 20% in early trading after the company announced better-than-expected second-quarter financial results.<img src=\"https://static.tigerbbs.com/e53bde2547c073caae91fe550b997b23\" tg-width=\"856\" tg-height=\"603\" referrerpolicy=\"no-referrer\">3D Systems reported quarterly earnings of 12 cents per share, which beat the estimate of 5 cents per share. The company reported quarterly revenue of $162.6 million, which beat the estimate of $143.28 million.</p>\n<p>3D Systems said its revenue results reflect double-digit growth on a consecutive quarter over quarter and year over year basis.</p>\n<p>\"Not only is the global economy rebounding, but additive manufacturing is being implemented at an increasing rate in production as companies seek a more capable and flexible supply chain for critical components,\" said<b> Jeffrey Graves</b>, president and CEO of 3D Systems.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3D Systems Corp surged more than 20% in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3D Systems Corp surged more than 20% in early trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-10 21:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>3D</b> <b>Systems</b> <b>Corp</b> surged more than 20% in early trading after the company announced better-than-expected second-quarter financial results.<img src=\"https://static.tigerbbs.com/e53bde2547c073caae91fe550b997b23\" tg-width=\"856\" tg-height=\"603\" referrerpolicy=\"no-referrer\">3D Systems reported quarterly earnings of 12 cents per share, which beat the estimate of 5 cents per share. The company reported quarterly revenue of $162.6 million, which beat the estimate of $143.28 million.</p>\n<p>3D Systems said its revenue results reflect double-digit growth on a consecutive quarter over quarter and year over year basis.</p>\n<p>\"Not only is the global economy rebounding, but additive manufacturing is being implemented at an increasing rate in production as companies seek a more capable and flexible supply chain for critical components,\" said<b> Jeffrey Graves</b>, president and CEO of 3D Systems.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DDD":"3D系统"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111125748","content_text":"3D Systems Corp surged more than 20% in early trading after the company announced better-than-expected second-quarter financial results.3D Systems reported quarterly earnings of 12 cents per share, which beat the estimate of 5 cents per share. The company reported quarterly revenue of $162.6 million, which beat the estimate of $143.28 million.\n3D Systems said its revenue results reflect double-digit growth on a consecutive quarter over quarter and year over year basis.\n\"Not only is the global economy rebounding, but additive manufacturing is being implemented at an increasing rate in production as companies seek a more capable and flexible supply chain for critical components,\" said Jeffrey Graves, president and CEO of 3D Systems.","news_type":1,"symbols_score_info":{"DDD":0.9}},"isVote":1,"tweetType":1,"viewCount":3099,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898223484,"gmtCreate":1628502515048,"gmtModify":1703507172716,"author":{"id":"3584363966051201","authorId":"3584363966051201","name":"ANGELINE","avatar":"https://static.tigerbbs.com/07743f37ca0238b3fc5f71f589bbfd48","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584363966051201","idStr":"3584363966051201"},"themes":[],"htmlText":"Great ","listText":"Great ","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/898223484","repostId":"2158413272","repostType":4,"repost":{"id":"2158413272","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1628489696,"share":"https://ttm.financial/m/news/2158413272?lang=en_US&edition=fundamental","pubTime":"2021-08-09 14:14","market":"us","language":"en","title":"Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd","url":"https://stock-news.laohu8.com/highlight/detail?id=2158413272","media":"Reuters","summary":"JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of Pfizer's COVID-19 vaccine felt","content":"<p>JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>'s COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial survey in Israel.</p>\n<p>Israel began offering the booster shots about 10 days ago to people over age 60 as part of efforts to slow the spread of the highly contagious Delta variant. That effectively turned Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration.</p>\n<p>Israel's largest healthcare provider, Clalit, said on Sunday it had administered a third dose of the Pfizer/<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> vaccine to more than 240,000 people.</p>\n<p>About 4,500 people, all of whom received the booster shot from July 30 to Aug. 1, responded to questions and were included in the survey.</p>\n<p>Eighty-eight percent of participants in the survey said that in the days after receiving the third shot, they felt \"similar or better\" to how they felt after the second shot.</p>\n<p>Thirty-one percent reported some side effect, the most common being soreness at the injection site.</p>\n<p>About 0.4% said they suffered from difficulty breathing, and 1% said they sought medical treatment due to one or more side effect.</p>\n<p>Ran Balicer, Clalit's chief innovation officer, said that even though the results are \"initial and self-reported\", they allow a comparison of side effects with the second dose, and \"it turns out that in most cases they are similar or less in the booster.\"</p>\n<p>\"Although we do not yet have long-term research on the efficacy and safety of the third booster dose, for the personal risk management of any person aged 60 plus, these findings continue to point to the benefit of immunization now, along with careful behavior among adults and avoiding gathering in closed spaces,\" Balicer said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIsraeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-09 14:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>'s COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial survey in Israel.</p>\n<p>Israel began offering the booster shots about 10 days ago to people over age 60 as part of efforts to slow the spread of the highly contagious Delta variant. That effectively turned Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration.</p>\n<p>Israel's largest healthcare provider, Clalit, said on Sunday it had administered a third dose of the Pfizer/<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> vaccine to more than 240,000 people.</p>\n<p>About 4,500 people, all of whom received the booster shot from July 30 to Aug. 1, responded to questions and were included in the survey.</p>\n<p>Eighty-eight percent of participants in the survey said that in the days after receiving the third shot, they felt \"similar or better\" to how they felt after the second shot.</p>\n<p>Thirty-one percent reported some side effect, the most common being soreness at the injection site.</p>\n<p>About 0.4% said they suffered from difficulty breathing, and 1% said they sought medical treatment due to one or more side effect.</p>\n<p>Ran Balicer, Clalit's chief innovation officer, said that even though the results are \"initial and self-reported\", they allow a comparison of side effects with the second dose, and \"it turns out that in most cases they are similar or less in the booster.\"</p>\n<p>\"Although we do not yet have long-term research on the efficacy and safety of the third booster dose, for the personal risk management of any person aged 60 plus, these findings continue to point to the benefit of immunization now, along with careful behavior among adults and avoiding gathering in closed spaces,\" Balicer said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158413272","content_text":"JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of Pfizer's COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial survey in Israel.\nIsrael began offering the booster shots about 10 days ago to people over age 60 as part of efforts to slow the spread of the highly contagious Delta variant. That effectively turned Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration.\nIsrael's largest healthcare provider, Clalit, said on Sunday it had administered a third dose of the Pfizer/BioNTech SE vaccine to more than 240,000 people.\nAbout 4,500 people, all of whom received the booster shot from July 30 to Aug. 1, responded to questions and were included in the survey.\nEighty-eight percent of participants in the survey said that in the days after receiving the third shot, they felt \"similar or better\" to how they felt after the second shot.\nThirty-one percent reported some side effect, the most common being soreness at the injection site.\nAbout 0.4% said they suffered from difficulty breathing, and 1% said they sought medical treatment due to one or more side effect.\nRan Balicer, Clalit's chief innovation officer, said that even though the results are \"initial and self-reported\", they allow a comparison of side effects with the second dose, and \"it turns out that in most cases they are similar or less in the booster.\"\n\"Although we do not yet have long-term research on the efficacy and safety of the third booster dose, for the personal risk management of any person aged 60 plus, these findings continue to point to the benefit of immunization now, along with careful behavior among adults and avoiding gathering in closed spaces,\" Balicer said.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":3900,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}